Endothelial-Rac1 Is Not Required for Tumor Angiogenesis unless αvβ3-Integrin Is Absent
Author(s) -
Gabriela D’Amico,
Stephen D. Robinson,
Mitchel Germain,
Louise E. Reynolds,
Gareth J. Thomas,
George Elia,
Garry Saunders,
Marcus Fruttiger,
Victor L. J. Tybulewicz,
Georgia Mavria,
Kairbaan HodivalaDilke
Publication year - 2010
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0009766
Subject(s) - angiogenesis , rac1 , cancer research , biology , integrin , neovascularization , endothelial stem cell , microbiology and biotechnology , in vitro , cell , signal transduction , biochemistry
Endothelial cell migration is an essential aspect of tumor angiogenesis. Rac1 activity is needed for cell migration in vitro implying a requirement for this molecule in angiogenesis in vivo . However, a precise role for Rac1 in tumor angiogenesis has never been addressed. Here we show that depletion of endothelial Rac1 expression in adult mice, unexpectedly, has no effect on tumor growth or tumor angiogenesis. In addition, repression of Rac1 expression does not inhibit VEGF-mediated angiogenesis in vivo or ex vivo , nor does it affect chemotactic migratory responses to VEGF in 3-dimensions. In contrast, the requirement for Rac1 in tumor growth and angiogenesis becomes important when endothelial β3 -integrin levels are reduced or absent: the enhanced tumor growth, tumor angiogenesis and VEGF-mediated responses in β3 -null mice are all Rac1-dependent. These data indicate that in the presence of αv β3 -integrin Rac1 is not required for tumor angiogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom